Prosonix
Oxford
About Prosonix
Prosonix is world leader in the commercialization of proprietary pharmaceutical ultrasonic particle engineering technologies and added value ultrasonic process chemistry solutions. A core expertise is the development of new ‘molecule to particle' methods for manufacture of inhaled medicines.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $45.0M
- Funding stage: M&A
- Last round: Series B (May 2012)
- Website: prosonix.co.uk
- Phone: +441865784250
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/prosonix-2908512 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.